glp-1 for obesity Chart: 1 in 8 Americans Now Use Drugs Weight Loss Researchers find GLP-1 medications safe

The ratio of p-AMPK to t-AMPK (j) and BACE1 expressions (k) were quantified

GLP-1s may additionally impact other physiological changes observed in the perimenopausal period, including vasomotor symptoms like hot flashes and night sweats, declines in bone health, and unhealthy changes in body composition (gains in fat mass and declines in muscle mass), but whether these impacts are beneficial or harmful for women's health remains unknown

[DOI] [PubMed] [Google Scholar] McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ

Random glucose GWAS in 493,036 individuals provides insights into diabetes pathophysiology, complications and treatment stratification

This pause gives your body a clean slate as you move into this exciting next chapter